The efficacy of systemic antibiotics in the treatment of granulating wounds.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002056:Burns / Q000188:drug therapy*; D002506:Cephalexin / Q000627:therapeutic use; D002509:Cephaloridine / Q000627:therapeutic use; D002512:Cephalothin / Q000032:analysis / Q000627:therapeutic use; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000188:drug therapy; D006097:Granulation Tissue / Q000032:analysis / Q000187:drug effects* / Q000473:pathology; D007612:Kanamycin / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy; D014947:Wounds and Injuries / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D002509:Cephaloridine; D002506:Cephalexin; D002512:Cephalothin